Online Yoga Added to Usual Care for Frequent Migraine
Tests an online Hatha yoga program added to usual medicine in adults with frequent migraine.
Plain-language title generated from the registry record
Registry title: Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
Key facts
- Where
- Seville, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07694063, who can take part
Where in Spain
- University Hospital Virgen del RocioSeville, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Seville
- Trial code
- NCT07694063
- Record updated
- 9 July 2026
- Original description
This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.Read full original descriptionShow less
A Randomized Controlled Trial of an Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine
This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.
Inclusion: Adults aged 18-65 years; Diagnosis of episodic high-frequency migraine according to ICHD criteria; Diagnosis confirmed by a neurologist; At least 1-year history of migraine; Receiving stable pharmacological treatment for ≥3 months before enrollment; Willing to maintain stable medication during the study; Ability to understand study procedures and complete assessments; Signed informed consent; Willingness to be randomized.
Exclusion: Use of more than one preventive migraine medication; Other significant neurological disorders; Severe psychiatric conditions affecting participation; Medical contraindications to moderate physical activity; Chronic migraine (≥15 headache days/month); Lack of Spanish language comprehension; Lack of internet access or digital skills for online intervention.